|
appendicitis CHOP eMERGE III |
Appendicitis |
CHOP |
Case, Control |
|
|
|
|
|
Harvard Implementation |
Appendicitis |
|
Case, Control |
877 |
771 |
|
|
|
GH/UW Implementation |
Appendicitis |
|
Case, Control |
0 |
1,761 |
|
|
|
NU appendicitis cases |
Appendicitis |
Northwestern University |
Case Only |
30 |
|
100% |
|
|
Appendicitis Case 1, Control |
Appendicitis |
Cincinnati Children's Hospital Medical Center |
Case, Control |
15 |
20 |
93%, 100% |
|
|
Appendicitis Case 2-MED |
Appendicitis |
Cincinnati Children's Hospital Medical Center |
Case Only |
|
|
90% |
|
|
CHOP implementation Case 1 and Controls |
Appendicitis |
CHOP |
Case, Control |
|
|
86%, 100% |
|
|
CHOP implementation Case 2 |
Appendicitis |
CHOP |
Case Only |
2 |
|
50% |
|
|
CHOP implementation Case 3 |
Appendicitis |
|
Case Only |
10 |
|
50% |
|
|
Vanderbilt Implementation of CHD |
MidSouth CDRN - Coronary Heart Disease Algorithm |
Vanderbilt University |
Case Only |
|
|
98% |
95% |
|
Coronary Heart Disease-Columbia |
MidSouth CDRN - Coronary Heart Disease Algorithm |
Columbia University |
Case Only |
|
|
|
|
|
NU Validation and Results |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Northwestern University Feinberg School of Medicine |
Case, Control |
334 |
720 |
98%, 92% |
92%, 98% |
|
VU Implementation |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Vanderbilt University |
Case, Control |
1,642 |
2,862 |
|
|
|
GH/UW Verification |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Group Health and University of Washington |
Case, Control |
479 |
319 |
100%, 100% |
100%, 100% |
|
CHOP implementation |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
CHOP |
Case, Control |
|
|
92%, 100% |
|
|
Harvard Implementation |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Harvard Medical School |
Case, Control |
573 |
1,446 |
|
|
|
GERD Implementation - Columbia |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Columbia University |
Case, Control |
76 |
259 |
|
|
|
Mayo Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
|
Case, Control |
416 |
278 |
|
|
|
Nortwestern University e3 Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Northwestern University |
Case, Control |
48 |
133 |
|
|
|
Updated Geisinger Impl |
CAAD (Carotid Artery Atherosclerosis Disease) |
Geisinger |
Case, Control |
|
|
|
|
|
Marshfield implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
71 |
435 |
100%, 100% |
100% |
|
Group Health/University of Washington CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Group Health/University of Washington |
Case, Control |
300 |
4,475 |
96%, 100% |
|
|
Marshfield Implementation 2 |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
193 |
4,170 |
100%, 100% |
|
|
Mayo Clinic CAAD Evaluation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo Clinic |
Case, Control |
|
|
100% |
72% |
|
Mayo CAAD cases and controls |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo |
Case, Control |
13 |
|
100% |
71% |
